SlideShare a Scribd company logo
RUSSIAN ACADEMY OF SCIENCES
Institute of Macromolecular Compounds
St. Petersburg
PROF. STEFANO FIORUCCI
SECTION OF GASTROENTEROLOGY
DEPARTMENT OF SURGERY AND BIOMEDICAL SCIENCES,
UNIVERSITY OF PERUGIA MEDICAL SCHOOL
BILE ACID ACTIVATED RECEPTORS: TALE OF A MULTITASKING
FAMILY
Nuclear receptors (NRs) are a large family of ligand-activated transcription
factors (Human NR superfamily include 48 members) which control numerous
metabolic pathways and processes in various organs, ranging from
proliferation to apoptosis, differentiation and energy homeostasis. Nuclear
receptors as valuable potential targets for the development of therapeutic
agents against a number of pathological conditions and diseases. Bile acids,
are the end-products of cholestrol metabolism synthesized in the liver and
secreted in the gastrointestinal tract where they undergoes a transformation
by the intestinal microbiota. In addition to their role in regulating lipid and
cholesterol absorption in the small intestinal, bile acids area signaling
molecules acting on wide range of receptors collectively known as Bile acid
activated receptors (BARs). This family includes NR such as The farnesoid
X receptor (FXR), the Vitamin D receptor (VDR), the pregnane-x-receptor
(PXR) among others and G-protein coupled receptors such as GPBAR1
(TGR5). FXR is a bile sensor that acts in coordination with other nuclear
receptors to regulate essential steps in bile acid uptake, metabolism and
excretion. FXR shares the general architecture of other NR receptors acting
as an heterodimer with RXR (retinoid-x-receptor). In addition, FXR is
involved in lipid and glucose homeostasis. FXR ligands endowed with
agonistic activity are under development for the treatment of metabolic
disorders linked to insulin resistance. GPBAR1 is a receptor regulating
energy expenditure and has relevance in the treatment of insulin resistance
and diabetes along with inflammation and immune dysfunction.
Objectives
- To describe cholesterol/bile acid metabolism and receptors
- Biology of BAR
- Medicinal chemistry of FXR and GPBAR1
-Potential clinical application

More Related Content

Similar to Bile acid activated receptors

Bile acids and NSAIDs and ASA
Bile acids and NSAIDs and ASABile acids and NSAIDs and ASA
Bile acids and NSAIDs and ASA
Attività scientifica
 
Peroxisomes in dermatology
Peroxisomes in dermatologyPeroxisomes in dermatology
Peroxisomes in dermatology
gueste13bd2
 
Final nuclear receptor
Final nuclear receptorFinal nuclear receptor
Final nuclear receptor
DR.HARI SINGH GOUR
 
Nuclear receptors for developing new drug therapy By Dr. Armaan Singh
Nuclear receptors for developing new drug therapy By Dr. Armaan SinghNuclear receptors for developing new drug therapy By Dr. Armaan Singh
Nuclear receptors for developing new drug therapy By Dr. Armaan Singh
Dr. Armaan Singh
 
Nuclear receptor
Nuclear receptorNuclear receptor
Nuclear receptor
DivyaRaniSharma1
 
Nuclear receptors as target of new drug therapy
Nuclear receptors as target of new drug therapyNuclear receptors as target of new drug therapy
Nuclear receptors as target of new drug therapy
Habibur Rahman
 
Peroxisome proliferator activated receptors (PPARs)
Peroxisome proliferator activated receptors (PPARs)Peroxisome proliferator activated receptors (PPARs)
Peroxisome proliferator activated receptors (PPARs)
Dr.Kavitha Vivek
 
Matsunami et al., 2010 4th
Matsunami et al., 2010 4thMatsunami et al., 2010 4th
Brian Covello: Diabetes Research Proposal
Brian Covello: Diabetes Research ProposalBrian Covello: Diabetes Research Proposal
Brian Covello: Diabetes Research Proposal
Brian Covello
 
Different Therapeutic Aspects of Peroxisomes Proliferator-Activated Receptors
Different Therapeutic Aspects of Peroxisomes Proliferator-Activated ReceptorsDifferent Therapeutic Aspects of Peroxisomes Proliferator-Activated Receptors
Different Therapeutic Aspects of Peroxisomes Proliferator-Activated Receptors
AI Publications
 
DƯỢC LÝ HỌC HỆ TIÊU HÓA
DƯỢC LÝ HỌC HỆ TIÊU HÓADƯỢC LÝ HỌC HỆ TIÊU HÓA
DƯỢC LÝ HỌC HỆ TIÊU HÓA
SoM
 
Anti-cancer as Protein kinase C & tyrosine inhibitor.
Anti-cancer as Protein kinase C & tyrosine inhibitor.Anti-cancer as Protein kinase C & tyrosine inhibitor.
Anti-cancer as Protein kinase C & tyrosine inhibitor.
Omer Bayazeid, PhD
 
Enzyme inhibitors general
Enzyme inhibitors generalEnzyme inhibitors general
Enzyme inhibitors general
Dr. Manoj Kumbhare
 
Evaluation of the effect of GIT 27 & TAK 242 on drug-induced liver injury
Evaluation of the effect of GIT 27 & TAK 242 on drug-induced liver injuryEvaluation of the effect of GIT 27 & TAK 242 on drug-induced liver injury
Evaluation of the effect of GIT 27 & TAK 242 on drug-induced liver injury
Alaa Fadhel Hassan Alwazni
 
Drug Transport and drug target.pptx
Drug Transport and drug target.pptxDrug Transport and drug target.pptx
Drug Transport and drug target.pptx
mrcopyxerox
 
Molecular Mechanisms of Acute Radiation Disease - Histamine & Serotonin.
 Molecular Mechanisms of Acute Radiation Disease - Histamine & Serotonin. Molecular Mechanisms of Acute Radiation Disease - Histamine & Serotonin.
Molecular Mechanisms of Acute Radiation Disease - Histamine & Serotonin.
Dmitri Popov
 
Evaluation of the effect of GIT 27 & TAK 242 on drug-induced liver injury
Evaluation of the effect of GIT 27 & TAK 242 on drug-induced liver injuryEvaluation of the effect of GIT 27 & TAK 242 on drug-induced liver injury
Evaluation of the effect of GIT 27 & TAK 242 on drug-induced liver injury
Alaa Fadhel Hassan Alwazni
 
Drug transporter polymorphism
Drug transporter polymorphismDrug transporter polymorphism
Drug transporter polymorphism
Sreenivasa Reddy Thalla
 
From Nutrigenomics to nutritional systems biology of fatty acid sensing
From Nutrigenomics to nutritional systems biology of fatty acid sensingFrom Nutrigenomics to nutritional systems biology of fatty acid sensing
From Nutrigenomics to nutritional systems biology of fatty acid sensing
Norwich Research Park
 

Similar to Bile acid activated receptors (20)

Bile acids and NSAIDs and ASA
Bile acids and NSAIDs and ASABile acids and NSAIDs and ASA
Bile acids and NSAIDs and ASA
 
Peroxisomes in dermatology
Peroxisomes in dermatologyPeroxisomes in dermatology
Peroxisomes in dermatology
 
Final nuclear receptor
Final nuclear receptorFinal nuclear receptor
Final nuclear receptor
 
Nuclear receptors for developing new drug therapy By Dr. Armaan Singh
Nuclear receptors for developing new drug therapy By Dr. Armaan SinghNuclear receptors for developing new drug therapy By Dr. Armaan Singh
Nuclear receptors for developing new drug therapy By Dr. Armaan Singh
 
Nuclear receptor
Nuclear receptorNuclear receptor
Nuclear receptor
 
SURF Poster
SURF PosterSURF Poster
SURF Poster
 
Nuclear receptors as target of new drug therapy
Nuclear receptors as target of new drug therapyNuclear receptors as target of new drug therapy
Nuclear receptors as target of new drug therapy
 
Peroxisome proliferator activated receptors (PPARs)
Peroxisome proliferator activated receptors (PPARs)Peroxisome proliferator activated receptors (PPARs)
Peroxisome proliferator activated receptors (PPARs)
 
Matsunami et al., 2010 4th
Matsunami et al., 2010 4thMatsunami et al., 2010 4th
Matsunami et al., 2010 4th
 
Brian Covello: Diabetes Research Proposal
Brian Covello: Diabetes Research ProposalBrian Covello: Diabetes Research Proposal
Brian Covello: Diabetes Research Proposal
 
Different Therapeutic Aspects of Peroxisomes Proliferator-Activated Receptors
Different Therapeutic Aspects of Peroxisomes Proliferator-Activated ReceptorsDifferent Therapeutic Aspects of Peroxisomes Proliferator-Activated Receptors
Different Therapeutic Aspects of Peroxisomes Proliferator-Activated Receptors
 
DƯỢC LÝ HỌC HỆ TIÊU HÓA
DƯỢC LÝ HỌC HỆ TIÊU HÓADƯỢC LÝ HỌC HỆ TIÊU HÓA
DƯỢC LÝ HỌC HỆ TIÊU HÓA
 
Anti-cancer as Protein kinase C & tyrosine inhibitor.
Anti-cancer as Protein kinase C & tyrosine inhibitor.Anti-cancer as Protein kinase C & tyrosine inhibitor.
Anti-cancer as Protein kinase C & tyrosine inhibitor.
 
Enzyme inhibitors general
Enzyme inhibitors generalEnzyme inhibitors general
Enzyme inhibitors general
 
Evaluation of the effect of GIT 27 & TAK 242 on drug-induced liver injury
Evaluation of the effect of GIT 27 & TAK 242 on drug-induced liver injuryEvaluation of the effect of GIT 27 & TAK 242 on drug-induced liver injury
Evaluation of the effect of GIT 27 & TAK 242 on drug-induced liver injury
 
Drug Transport and drug target.pptx
Drug Transport and drug target.pptxDrug Transport and drug target.pptx
Drug Transport and drug target.pptx
 
Molecular Mechanisms of Acute Radiation Disease - Histamine & Serotonin.
 Molecular Mechanisms of Acute Radiation Disease - Histamine & Serotonin. Molecular Mechanisms of Acute Radiation Disease - Histamine & Serotonin.
Molecular Mechanisms of Acute Radiation Disease - Histamine & Serotonin.
 
Evaluation of the effect of GIT 27 & TAK 242 on drug-induced liver injury
Evaluation of the effect of GIT 27 & TAK 242 on drug-induced liver injuryEvaluation of the effect of GIT 27 & TAK 242 on drug-induced liver injury
Evaluation of the effect of GIT 27 & TAK 242 on drug-induced liver injury
 
Drug transporter polymorphism
Drug transporter polymorphismDrug transporter polymorphism
Drug transporter polymorphism
 
From Nutrigenomics to nutritional systems biology of fatty acid sensing
From Nutrigenomics to nutritional systems biology of fatty acid sensingFrom Nutrigenomics to nutritional systems biology of fatty acid sensing
From Nutrigenomics to nutritional systems biology of fatty acid sensing
 

More from Attività scientifica

Microbiota 2019
Microbiota  2019 Microbiota  2019
Microbiota 2019
Attività scientifica
 
Il punto sul microbiota e le malattie umane- Covegno scientifico
Il  punto sul microbiota e le malattie umane- Covegno scientifico Il  punto sul microbiota e le malattie umane- Covegno scientifico
Il punto sul microbiota e le malattie umane- Covegno scientifico
Attività scientifica
 
Microbiota update perugia-
Microbiota  update perugia- Microbiota  update perugia-
Microbiota update perugia-
Attività scientifica
 
Microbiota perugia 20 aprile 2018
Microbiota perugia 20 aprile 2018Microbiota perugia 20 aprile 2018
Microbiota perugia 20 aprile 2018
Attività scientifica
 
Portal hypertension and gastrointestinal bleeding
Portal hypertension  and gastrointestinal bleedingPortal hypertension  and gastrointestinal bleeding
Portal hypertension and gastrointestinal bleeding
Attività scientifica
 
Ade 2018 emorragie Attività didattica integrativa 28 novembre 2017
Ade 2018 emorragie  Attività didattica integrativa  28 novembre 2017Ade 2018 emorragie  Attività didattica integrativa  28 novembre 2017
Ade 2018 emorragie Attività didattica integrativa 28 novembre 2017
Attività scientifica
 
Ocaliva causes 114 serious side effects and 24 deaths according to FDA
Ocaliva  causes  114 serious side effects and 24 deaths according to FDAOcaliva  causes  114 serious side effects and 24 deaths according to FDA
Ocaliva causes 114 serious side effects and 24 deaths according to FDA
Attività scientifica
 
Metabolomic profile of the probiotic of VSL#3 in vitro
Metabolomic profile of the probiotic of VSL#3 in  vitro   Metabolomic profile of the probiotic of VSL#3 in  vitro
Metabolomic profile of the probiotic of VSL#3 in vitro
Attività scientifica
 
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
Attività scientifica
 
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages  GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
Attività scientifica
 
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
Attività scientifica
 
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability
Digestive Disease Week 2017 The probiotic VSL#3   shows metabolic instability Digestive Disease Week 2017 The probiotic VSL#3   shows metabolic instability
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability
Attività scientifica
 
Digestive Disease Week 2017 BAR704 reduces liver fibrosis
Digestive  Disease  Week 2017    BAR704   reduces liver fibrosisDigestive  Disease  Week 2017    BAR704   reduces liver fibrosis
Digestive Disease Week 2017 BAR704 reduces liver fibrosis
Attività scientifica
 
BAR501 a selective TGR5 ligand attenuates NASH
BAR501 a selective TGR5 ligand attenuates NASHBAR501 a selective TGR5 ligand attenuates NASH
BAR501 a selective TGR5 ligand attenuates NASH
Attività scientifica
 
NAFLD/NASH - 3 febbraio 2017-
NAFLD/NASH - 3  febbraio 2017-NAFLD/NASH - 3  febbraio 2017-
NAFLD/NASH - 3 febbraio 2017-
Attività scientifica
 
New official web site
New  official web siteNew  official web site
New official web site
Attività scientifica
 
Tgr5 and gastric cancer ddw2016
Tgr5 and gastric cancer  ddw2016Tgr5 and gastric cancer  ddw2016
Tgr5 and gastric cancer ddw2016
Attività scientifica
 
Bar501 and inflammation ddw 2016
Bar501 and inflammation ddw 2016Bar501 and inflammation ddw 2016
Bar501 and inflammation ddw 2016
Attività scientifica
 
Shp and liver fibrosis ddw 2016
Shp and liver fibrosis  ddw 2016Shp and liver fibrosis  ddw 2016
Shp and liver fibrosis ddw 2016
Attività scientifica
 
Ccr5 and colitis ddw 2016
Ccr5 and  colitis ddw 2016Ccr5 and  colitis ddw 2016
Ccr5 and colitis ddw 2016
Attività scientifica
 

More from Attività scientifica (20)

Microbiota 2019
Microbiota  2019 Microbiota  2019
Microbiota 2019
 
Il punto sul microbiota e le malattie umane- Covegno scientifico
Il  punto sul microbiota e le malattie umane- Covegno scientifico Il  punto sul microbiota e le malattie umane- Covegno scientifico
Il punto sul microbiota e le malattie umane- Covegno scientifico
 
Microbiota update perugia-
Microbiota  update perugia- Microbiota  update perugia-
Microbiota update perugia-
 
Microbiota perugia 20 aprile 2018
Microbiota perugia 20 aprile 2018Microbiota perugia 20 aprile 2018
Microbiota perugia 20 aprile 2018
 
Portal hypertension and gastrointestinal bleeding
Portal hypertension  and gastrointestinal bleedingPortal hypertension  and gastrointestinal bleeding
Portal hypertension and gastrointestinal bleeding
 
Ade 2018 emorragie Attività didattica integrativa 28 novembre 2017
Ade 2018 emorragie  Attività didattica integrativa  28 novembre 2017Ade 2018 emorragie  Attività didattica integrativa  28 novembre 2017
Ade 2018 emorragie Attività didattica integrativa 28 novembre 2017
 
Ocaliva causes 114 serious side effects and 24 deaths according to FDA
Ocaliva  causes  114 serious side effects and 24 deaths according to FDAOcaliva  causes  114 serious side effects and 24 deaths according to FDA
Ocaliva causes 114 serious side effects and 24 deaths according to FDA
 
Metabolomic profile of the probiotic of VSL#3 in vitro
Metabolomic profile of the probiotic of VSL#3 in  vitro   Metabolomic profile of the probiotic of VSL#3 in  vitro
Metabolomic profile of the probiotic of VSL#3 in vitro
 
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
 
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages  GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
 
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
 
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability
Digestive Disease Week 2017 The probiotic VSL#3   shows metabolic instability Digestive Disease Week 2017 The probiotic VSL#3   shows metabolic instability
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability
 
Digestive Disease Week 2017 BAR704 reduces liver fibrosis
Digestive  Disease  Week 2017    BAR704   reduces liver fibrosisDigestive  Disease  Week 2017    BAR704   reduces liver fibrosis
Digestive Disease Week 2017 BAR704 reduces liver fibrosis
 
BAR501 a selective TGR5 ligand attenuates NASH
BAR501 a selective TGR5 ligand attenuates NASHBAR501 a selective TGR5 ligand attenuates NASH
BAR501 a selective TGR5 ligand attenuates NASH
 
NAFLD/NASH - 3 febbraio 2017-
NAFLD/NASH - 3  febbraio 2017-NAFLD/NASH - 3  febbraio 2017-
NAFLD/NASH - 3 febbraio 2017-
 
New official web site
New  official web siteNew  official web site
New official web site
 
Tgr5 and gastric cancer ddw2016
Tgr5 and gastric cancer  ddw2016Tgr5 and gastric cancer  ddw2016
Tgr5 and gastric cancer ddw2016
 
Bar501 and inflammation ddw 2016
Bar501 and inflammation ddw 2016Bar501 and inflammation ddw 2016
Bar501 and inflammation ddw 2016
 
Shp and liver fibrosis ddw 2016
Shp and liver fibrosis  ddw 2016Shp and liver fibrosis  ddw 2016
Shp and liver fibrosis ddw 2016
 
Ccr5 and colitis ddw 2016
Ccr5 and  colitis ddw 2016Ccr5 and  colitis ddw 2016
Ccr5 and colitis ddw 2016
 

Recently uploaded

GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
Areesha Ahmad
 
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdfSCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SELF-EXPLANATORY
 
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
NathanBaughman3
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
muralinath2
 
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
Sérgio Sacani
 
ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
muralinath2
 
in vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptxin vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptx
yusufzako14
 
Leaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdfLeaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdf
RenuJangid3
 
extra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdfextra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdf
DiyaBiswas10
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Sérgio Sacani
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
pablovgd
 
Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
muralinath2
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Sérgio Sacani
 
GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
Areesha Ahmad
 
role of pramana in research.pptx in science
role of pramana in research.pptx in sciencerole of pramana in research.pptx in science
role of pramana in research.pptx in science
sonaliswain16
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
Richard Gill
 
erythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptxerythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptx
muralinath2
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
Nistarini College, Purulia (W.B) India
 
EY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptxEY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptx
AlguinaldoKong
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
muralinath2
 

Recently uploaded (20)

GBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of LipidsGBSN - Biochemistry (Unit 5) Chemistry of Lipids
GBSN - Biochemistry (Unit 5) Chemistry of Lipids
 
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdfSCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
 
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
 
Hemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptxHemostasis_importance& clinical significance.pptx
Hemostasis_importance& clinical significance.pptx
 
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
THE IMPORTANCE OF MARTIAN ATMOSPHERE SAMPLE RETURN.
 
ESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptxESR_factors_affect-clinic significance-Pathysiology.pptx
ESR_factors_affect-clinic significance-Pathysiology.pptx
 
in vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptxin vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptx
 
Leaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdfLeaf Initiation, Growth and Differentiation.pdf
Leaf Initiation, Growth and Differentiation.pdf
 
extra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdfextra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdf
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
 
Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
 
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
Observation of Io’s Resurfacing via Plume Deposition Using Ground-based Adapt...
 
GBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram StainingGBSN- Microbiology (Lab 3) Gram Staining
GBSN- Microbiology (Lab 3) Gram Staining
 
role of pramana in research.pptx in science
role of pramana in research.pptx in sciencerole of pramana in research.pptx in science
role of pramana in research.pptx in science
 
Richard's entangled aventures in wonderland
Richard's entangled aventures in wonderlandRichard's entangled aventures in wonderland
Richard's entangled aventures in wonderland
 
erythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptxerythropoiesis-I_mechanism& clinical significance.pptx
erythropoiesis-I_mechanism& clinical significance.pptx
 
Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.Nucleic Acid-its structural and functional complexity.
Nucleic Acid-its structural and functional complexity.
 
EY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptxEY - Supply Chain Services 2018_template.pptx
EY - Supply Chain Services 2018_template.pptx
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
 

Bile acid activated receptors

  • 1. RUSSIAN ACADEMY OF SCIENCES Institute of Macromolecular Compounds St. Petersburg PROF. STEFANO FIORUCCI SECTION OF GASTROENTEROLOGY DEPARTMENT OF SURGERY AND BIOMEDICAL SCIENCES, UNIVERSITY OF PERUGIA MEDICAL SCHOOL BILE ACID ACTIVATED RECEPTORS: TALE OF A MULTITASKING FAMILY Nuclear receptors (NRs) are a large family of ligand-activated transcription factors (Human NR superfamily include 48 members) which control numerous metabolic pathways and processes in various organs, ranging from proliferation to apoptosis, differentiation and energy homeostasis. Nuclear receptors as valuable potential targets for the development of therapeutic agents against a number of pathological conditions and diseases. Bile acids, are the end-products of cholestrol metabolism synthesized in the liver and secreted in the gastrointestinal tract where they undergoes a transformation by the intestinal microbiota. In addition to their role in regulating lipid and cholesterol absorption in the small intestinal, bile acids area signaling molecules acting on wide range of receptors collectively known as Bile acid activated receptors (BARs). This family includes NR such as The farnesoid X receptor (FXR), the Vitamin D receptor (VDR), the pregnane-x-receptor (PXR) among others and G-protein coupled receptors such as GPBAR1 (TGR5). FXR is a bile sensor that acts in coordination with other nuclear receptors to regulate essential steps in bile acid uptake, metabolism and excretion. FXR shares the general architecture of other NR receptors acting as an heterodimer with RXR (retinoid-x-receptor). In addition, FXR is involved in lipid and glucose homeostasis. FXR ligands endowed with agonistic activity are under development for the treatment of metabolic disorders linked to insulin resistance. GPBAR1 is a receptor regulating energy expenditure and has relevance in the treatment of insulin resistance and diabetes along with inflammation and immune dysfunction. Objectives - To describe cholesterol/bile acid metabolism and receptors - Biology of BAR - Medicinal chemistry of FXR and GPBAR1